Acta Med. 2010, 53: 213-220
https://doi.org/10.14712/18059694.2016.79
How I Treat Elderly or Comorbid Patients with Chronic Lymphocytic Leukemia
Individual author index pages
Other articles of these authors
-
Biological Prognostic Markers in Chronic Lymphocytic Leukemia
Vladimíra Vroblová, Lukáš Smolej, Filip Vrbacký, Karolína Jankovičová, Monika Hrudková, Jaroslav Malý, Jan Krejsek
2009, Vol. 52, Issue 1, pp. 3-8 -
Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma – a Single-center, Retrospective Study
David Belada, Lukáš Smolej, Monika Hrudková, Pavla Štěpánková, Alice Sýkorová, Pavel Žák, Jiří Bukač, Jaroslav Malý
2007, Vol. 50, Issue 2, pp. 113-118 -
Plasma Concentrations of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Lymphoproliferative Disorders
Lukáš Smolej, Ctirad Andrýs, Vladimír Maisnar, Luděk Pour, Jaroslav Malý
2005, Vol. 48, Issue 1, pp. 57-58
